Rat Model Market Size, Share, Growth and Forecast 2032

Rat Model Market Insights

According to a report from Zion Market Research, the global Rat Model Market was valued at USD 1415.83 Million in 2023 and is projected to hit USD 2660.43 Million by 2032, with a compound annual growth rate (CAGR) of 7.26% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Rat Model Market industry over the next decade.

Request Free Sample

Global Rat Model Market: Overview      

Rat model is an animal model for research in biomedical science and psycology. Rats and humans both have similarities such as physiology, similar body organs, similar genetic structure to the humans and often suffer from the same diseases. A rat model has been used frequently in drug development, toxicology and various biomedical fields, including carcinogenicity testing.

Ongoing research for the development of treatment on neurology disorder and cancer coupled with the emergence of transgenic rat models is expected to fuel the demand of rat models in coming years. In addition, advancement in bioinformatics that leads the development of tools and software for analysis of data generated after pre-clinical research using rat models is anticipated to boost the growth of this market in coming years. However, rising concern about animal cruelty, ethical concerns as well as the threat from the advancement of zebra fish models is expected to hinder the growth of the market in the forecast period.

Rat Model Market: Growth Factors

Major boosting factors for Rat Model market are increasing non-government and government initiatives for fetal & maternal health all over the world, as per the analysts at Zion Market Research. In addition to this, rising awareness of manufacturers and willingness of players to spend in the development of fetal monitoring is also powering the development of Rat Model market. Moreover, enhanced models that assist to calculate the maternal parameters such as maternal heart rate, and blood pressure are also likely to fuel the development of Rat Model market in coming years. On the other hand, lack of intervening guidelines and technological challenges might hamper the development of the global Rat Model market in the years to come.

Rat Model Market: Segment Analysis

On the basis of Rat Types, the Rat Model market is likely to be ruled by Outbred segment. The extensive use of outbred rats in toxicology and safety assessment studies is expected to drive the growth of rat model in coming year.  

Depending on Technology, Embryonic Stem Cells segment is likely to hold the major share in the market and is anticipated to remain dominant throughout the forecast period. This is attributed to the ongoing developments of alternative methods to animal testing.

On the basis of application, Oncology segment hold the majority of Rat Model market share 2023.

Rat Model Market: Report Scope

Rat Model Market: Region Analysis

North America was the dominating regional market for rat model and further it would follow this trend in forecast period due to robust research activities. Europe held the second largest market share and Germany acquired the largest share in this region in 2023. An increasing number of academic and contract research organizations is the major driving factors of rat model in Asia Pacific region.  

Request Free Sample

Rat Model Market Players & Competitive Landscape

Some of key players in Rat Model Market are

• Covance, Inc
• Transviragen Inc.
• SAGE Labs
• Biomedical Research Models, Inc.
• genOway S.A.
• Transposagen Biopharmaceuticals
• Harlan Laboratories, Inc
• Charles River Laboratories

The global Rat Model Market is segmented as follows:   

By Rat Type

• Outbred
• Conditioned
• Knockout
• Others

By Technology

• Embryonic Stem Cells
• Microinjection
• Others

By Service

• Breeding
• Quarantine
• Cryopreservation
• Others

By Application

• Toxicology
• CNS
• Oncology
• Diabetes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa